Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.85745 | 82 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.36039 | 85 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.17264 | 84 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.13846 | 82 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.20167 | 84 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.03832 | 77 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.94745 | 76 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.74556 | 73 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.38805 | 70 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.67581 | 80 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.13837 | 84 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.96371 | 82 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.40311 | 78 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.35429 | 78 |